Isocitrate dehydrogenase mutations confer dasatinib hypersensitivity and SRC-dependence in intrahepatic cholangiocarcinoma

Intrahepatic cholangiocarcinoma (ICC) is an aggressive liver bile duct malignancy exhibiting frequent isocitrate dehydrogenase (IDH1/IDH2) mutations. Through a high-throughput drug screen of a large panel of cancer cell lines including 17 biliary tract cancers, we found that IDH mutant (IDHm) ICC ce...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Discov
Autors principals: Saha, Supriya K., Gordan, John D., Kleinstiver, Benjamin P., Vu, Phuong, Najem, Mortada S., Yeo, Jia-Chi, Shi, Lei, Kato, Yasutaka, Levin, Rebecca S., Webber, James T., Damon, Leah J., Egan, Regina K., Greninger, Patricia, McDermott, Ultan, Garnett, Mathew J., Jenkins, Roger L., Rieger-Christ, Kimberly M., Sullivan, Travis B., Hezel, Aram F., Liss, Andrew S., Mizukami, Yusuke, Goyal, Lipika, Ferrone, Cristina R., Zhu, Andrew X., Joung, J. Keith, Shokat, Kevan M., Benes, Cyril H., Bardeesy, Nabeel
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5458737/
https://ncbi.nlm.nih.gov/pubmed/27231123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-15-1442
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars